237 related articles for article (PubMed ID: 2538263)
1. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
Ohishi H; Yoshimura H; Uchida H; Sakaguchi H; Yoshioka T; Ohue S; Matsui T; Takaya A; Tsujii T
Cancer Chemother Pharmacol; 1989; 23 Suppl():S33-6. PubMed ID: 2538263
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and Gelfoam particles for hepatocellular carcinoma.
Uchida H; Ohishi H; Matsuo N; Nishimine K; Ohue S; Nishimura Y; Maeda M; Yoshioka T
Cardiovasc Intervent Radiol; 1990; 13(3):140-5. PubMed ID: 2171772
[TBL] [Abstract][Full Text] [Related]
3. [Cytofluorometric and histopathological studies on non-cancerous liver lesions after lipiodol-transcatheter arterial embolization].
Shimotsuma M; Taniguchi H; Sawai K; Takahashi T; Kagawa K; Kamachi M; Ashihara T; Shimamura Y
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2460-4. PubMed ID: 2843109
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
Matsuo N; Nishimine K; Uchida H; Nagano N; Nishimura Y; Oiyong G; Sakaguchi H; Yoshioka T; Ohue S; Ohishi H
Nihon Shokakibyo Gakkai Zasshi; 1992 Jul; 89(7):1415-24. PubMed ID: 1325006
[TBL] [Abstract][Full Text] [Related]
5. [The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
Suyama Y; Kitagawa Y; Horishi M; Shizumi Y; Yashige H; Fujii H; Miyoshi M
Gan No Rinsho; 1989 Aug; 35(9):983-9. PubMed ID: 2475651
[TBL] [Abstract][Full Text] [Related]
6. [Large amount of intra-arterial injection of iodized oil (Lipiodol) in the treatment of unresectable hepatoma].
Onodera H; Oikawa M; Abe M; Chida N; Kimura S; Goto Y
Rinsho Hoshasen; 1986 Feb; 31(2):269-73. PubMed ID: 3012157
[No Abstract] [Full Text] [Related]
7. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma.
Hirai K; Kawazoe Y; Yamashita K; Aoki Y; Fujimoto T; Sakai T; Majima Y; Abe M; Tanikawa K
Cancer Chemother Pharmacol; 1989; 23 Suppl():S37-41. PubMed ID: 2538264
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
[TBL] [Abstract][Full Text] [Related]
9. The outcome of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Hsieh MY; Wu DK; Lu SN; Wang LY; Chang WY
Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Nov; 6(11):628-35. PubMed ID: 2175816
[TBL] [Abstract][Full Text] [Related]
10. [Chemoembolization therapy of hepatocellular carcinoma-antitumor effect and side effect].
Saito Y; Sasaki T; Tarusawa K; Midorikawa H; Kanehira J; Ikami I; Yodono H; Takekawa SD
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3283-9. PubMed ID: 2848458
[TBL] [Abstract][Full Text] [Related]
11. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
[TBL] [Abstract][Full Text] [Related]
12. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
Matsuo N; Uchida H; Nishimine K; Soda S; Oshima M; Nakano H; Nagano N; Nishimura Y; Yoshioka T; Guo Q
J Vasc Interv Radiol; 1993; 4(4):543-9. PubMed ID: 8394758
[TBL] [Abstract][Full Text] [Related]
13. [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].
Sakaguchi H; Yoshimura H; Nishimura Y; Iwata K; Ohishi H; Uchida H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1725-30. PubMed ID: 2167644
[TBL] [Abstract][Full Text] [Related]
14. [Transarterial chemoembolization therapy of hepatocellular carcinoma using anticancer agents (mitomycin C and/or adriamycin) suspended in lipiodol].
Hidaka H; Kobayashi H; Ohyama M; Maeda T; Ikeda K; Nakajo M; Oyama T; Sonoda T; Ito Y; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Nov; 45(11):1430-40. PubMed ID: 3005959
[No Abstract] [Full Text] [Related]
15. [Preoperative chemo-embolization for treatment of hepatocellular carcinoma].
Okamura J; Monden M; Sakon M; Mori T; Kuroda C; Yoshioka H; Sakurai M; Wakasa K
Gan To Kagaku Ryoho; 1985 May; 12(5):1019-24. PubMed ID: 2986558
[TBL] [Abstract][Full Text] [Related]
16. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
Hirashima N
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
[TBL] [Abstract][Full Text] [Related]
17. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis.
Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Miura K
Cardiovasc Intervent Radiol; 1994; 17(2):76-80. PubMed ID: 8013027
[TBL] [Abstract][Full Text] [Related]
18. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effect of transcatheter arterial embolization as preoperative therapy of hepatocellular carcinoma].
Minematsu S; Taki Y; Tani T; Ozawa K; Tobe T
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1120-8. PubMed ID: 2997499
[TBL] [Abstract][Full Text] [Related]
20. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
